Airway function at one year: association with premorbid airway function, wheezing, and maternal smoking

C Dezateux1, J Stocks, A M Wade

  • 1Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. c.dezateux@ich.ucl.ac.uk

Thorax
|August 22, 2001
PubMed

Insights

Infant airway function at 1 year is linked to early respiratory issues and maternal smoking. Diminished airway function in early life and maternal smoking are key factors affecting infant lung health.

Area of Science:

  • Pediatric pulmonology
  • Respiratory system development
  • Infant health

Background:

  • Early life respiratory system development is crucial for long-term lung health.
  • Factors like prenatal development and early illness can impact infant respiratory function.
  • Understanding these early influences is key to preventing future respiratory conditions.

Purpose of the Study:

  • To investigate the relationship between early airway function, wheezing history, and maternal smoking on infant airway function at one year of age.
  • To identify key predictors of diminished airway function in infancy.

Main Methods:

  • Respiratory function, specifically specific airway conductance during end expiration (sGawEE), was measured in 100 healthy term infants at one year.
  • Pre-morbid measurements at 8 weeks and physician-diagnosed wheezing episodes were retrospectively analyzed.
  • Maternal smoking history was also recorded.

Main Results:

  • Infants with prior wheezing, maternal smoking, family history of asthma, or diminished premorbid sGawEE showed significantly reduced airway conductance at one year.
  • Multivariate analysis revealed maternal smoking and diminished premorbid sGawEE as independent predictors of reduced airway function at one year.

Conclusions:

  • Impaired airway development in early life and maternal smoking significantly impact infant airway function.
  • Diminished premorbid airway function may link early wheezing illness to later reduced airway function.
  • Maternal smoking is an avoidable cause of impaired infant airway development and function.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...